WINDLAS BIOTECH
Back to Income Statement
|
WINDLAS BIOTECH Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹760 Cr | ₹631 Cr | ₹513 Cr | ₹466 Cr | ₹428 Cr |
What is the latest Revenue of WINDLAS BIOTECH ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹760 Cr |
| Mar2024 | ₹631 Cr |
| Mar2023 | ₹513 Cr |
| Mar2022 | ₹466 Cr |
| Mar2021 | ₹428 Cr |
How is Revenue of WINDLAS BIOTECH Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹760 Cr | 20.43 | |
| Mar2024 | ₹631 Cr | 22.97 | |
| Mar2023 | ₹513 Cr | 10.12 | |
| Mar2022 | ₹466 Cr | 8.96 | |
| Mar2021 | ₹428 Cr | - | |
Compare Revenue of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,670.8 Cr | -5.4% | 4.8% | -17.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹410,442.0 Cr | 0.5% | -1.5% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,878.0 Cr | 5.5% | -0.2% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,301.0 Cr | 2.1% | 2.8% | 30.9% | Stock Analytics | |
| CIPLA | ₹109,030.0 Cr | 1.3% | -7.9% | -6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,023.0 Cr | 2% | 4.5% | 2.3% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -5.4% |
4.8% |
-17.6% |
| SENSEX | 0.5% |
0.8% |
7.2% |
You may also like the below Video Courses